Home > Financial Ratios > ALKEM LABORATORIES

ALKEM LABORATORIES
Core EBITDA Growth

    Back to All Ratios
ALKEM LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for ALKEM LABORATORIES
Please provide your vote to see the results

ALKEM LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 17.5940.03-17.601.8437.90

What is the latest Core EBITDA Growth ratio of ALKEM LABORATORIES ?

The latest Core EBITDA Growth ratio of ALKEM LABORATORIES is 17.59 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202517.59
Mar202440.03
Mar2023-17.60
Mar20221.84
Mar202137.90

How is Core EBITDA Growth of ALKEM LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 17.59
-56.06
Mar2024 40.03
Positive
Mar2023 -17.6
Negative
Mar2022 1.84
-95.15
Mar2021 37.9 -

Other Financial Ratios of ALKEM LABORATORIES


Compare Core EBITDA Growth ratio of peers of ALKEM LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALKEM LABORATORIES ₹60,020.7 Cr 0.4% 3.6% -3.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹123,675.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 1.4% -3.3% -7.2% Stock Analytics


ALKEM LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALKEM LABORATORIES

0.4%

3.6%

-3.8%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses